BraveRX Review: Three Actives, Three Ways to Lower Blood Pressure — And One Interaction Nobody Is Telling You About

What Is BraveRX?

BraveRX is a telemedicine platform selling compounded erectile dysfunction treatment. Its featured product, Surge Max, is an oral dissolving tablet containing tadalafil 15mg, sildenafil 40mg and apomorphine 3mg, priced at $159 per 12-count bottle — about $13.25 per dose — including what it describes as a complimentary doctor visit, daily access to medical support and free shipping, with a $20 discount on a first order. Independent listings put its wider range at roughly $119 to $169 depending on formulation.

The company describes itself as 'a technology platform that provides members access to board-certified, licensed physicians who can prescribe medications when medically necessary and clinically appropriate', working with a licensed US compounding pharmacy. It serves every state except North Dakota. Its domain has been registered for around six years, though the Katalys programme launched in February 2026 and its public review base remains small — around 21 Trustpilot reviews.

The oral dissolving format is a genuine convenience. Absorption across the oral mucosa can produce a faster onset than a swallowed tablet, and for this category timing matters.

Everything else on this page concerns what is in the tablet. There are three active drugs, all three lower blood pressure, two of them are the same class as each other, and one of them is not approved for this use in the United States.

What's In It & What It Costs

Prices are BraveRX's published figures as at 7 August 2026. At $13.25 per dose, Surge Max is not cheap against FDA-approved generics — Ro publishes generic sildenafil at $4 for 25mg, $6 for 50mg and $10 for 100mg per dose, and generic tadalafil from $8, all at strengths that exist in manufactured products and all reviewed by the FDA. The comparison matters because what you are paying the premium for is a combination nobody has studied.

The Three Actives — and Why the Combination Matters

Surge Max is a compounded preparation. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, efficacy or manufacturing quality. Independent coverage notes plainly that BraveRX's compound formulations 'are not individually FDA-approved as a combined product'.

The first problem is the two PDE5 inhibitors. Sildenafil and tadalafil work through the same mechanism and both lower blood pressure. Combining them is not an FDA-approved regimen and offers no established advantage over an adequate dose of either, while the hypotensive effects are additive. The strengths are also non-standard — approved sildenafil comes as 25, 50 and 100mg and tadalafil as 2.5, 5, 10 and 20mg — which is itself the signature of a compounded product.

The second problem is apomorphine, and it deserves careful explanation because almost nobody buying this will recognise the name. Apomorphine is a dopamine agonist, not a PDE5 inhibitor. It is not approved in the United States for erectile dysfunction. Its US approvals are Apokyn, a subcutaneous injection, and Kynmobi, a sublingual film, both for 'off' episodes in Parkinson's disease. A sublingual apomorphine product for ED, Uprima, was developed and marketed in Europe but never approved in the US and was subsequently withdrawn.

What the approved apomorphine labelling says matters here. Apomorphine causes nausea and vomiting frequently enough that its Parkinson's use requires starting an antiemetic — trimethobenzamide 300mg three times daily — three days before the first dose. And it carries a contraindication that is the single most important thing on this page: concomitant use with 5HT3 antagonist antiemetics, including ondansetron, granisetron, dolasetron and palonosetron, is contraindicated 'based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron'.

In fairness on dose: 3mg is modest relative to Parkinson's dosing, and sublingual bioavailability differs from injection, so systemic exposure here is likely lower than in that setting. But the contraindication in the label is not expressed as dose-dependent, and the additive hypotension from stacking apomorphine on top of two PDE5 inhibitors is a concern regardless of how modest each component looks in isolation.

The Consultation Process

Eligibility

• •BraveRX states availability in every state except North Dakota, with eligibility determined by a board-certified physician from your online intake.
• •This is the warning to read twice. If you take ondansetron — commonly dispensed as Zofran, and routinely offered as an anti-nausea add-on by GLP-1 telehealth providers — do not take a product containing apomorphine. Apomorphine's approved labelling contraindicates concomitant use with ondansetron and other 5HT3 antagonists on the basis of reported profound hypotension and loss of consciousness. Anyone on a weight-loss programme who has ondansetron in the cupboard for GLP-1 nausea is exactly the person at risk here, and nothing in this product's marketing flags it.
• •PDE5 inhibitors are absolutely contraindicated with nitrates in any form — nitroglycerin, isosorbide mononitrate or dinitrate, and recreational amyl nitrite 'poppers'. Because Surge Max contains two of them, that warning applies with more force, not less.
• •Caution and clinician judgement are required with alpha-blockers for prostate or blood pressure conditions, in significant cardiovascular disease, recent stroke or heart attack, uncontrolled hypertension or hypotension, and in anyone advised against sexual activity on cardiac grounds.
• •Apomorphine can cause orthostatic hypotension, nausea and vomiting, somnolence and — in its Parkinson's use — sudden onset of sleep and hallucinations. Do not drive until you know how it affects you.
• •Common PDE5 inhibitor side effects include headache, flushing, nasal congestion, indigestion, back or muscle ache and visual disturbance. Priapism — an erection lasting more than four hours — is a medical emergency. Sudden vision or hearing loss requires stopping the medication and urgent assessment.
• •Erectile dysfunction is frequently the first presenting sign of cardiovascular disease, diabetes or a hormonal disorder. New-onset symptoms deserve proper assessment for those causes rather than symptomatic treatment alone.

Prescribers, Testing & Pharmacy

Delivery & Availability

Free shipping on all orders, with availability in every state except North Dakota.

• •Doctor consultation included in the price rather than billed separately
• •Daily access to medical support advertised
• •Free shipping on all orders
• •Oral dissolving format offers faster onset than a swallowed tablet
• •$20 discount on a first order
• •Available in 49 states
• •Ingredient strengths are disclosed, which several competitors do not do

Fees, Cancellation & Refunds

Insurance & HSA/FSA

Pros & Cons

Who BraveRX May Be Best For

• •We do not have a group we would recommend this to on the current information
• •At most: men with no cardiovascular history, taking no nitrates, alpha-blockers or ondansetron, who have discussed the three-drug combination with a clinician who knows their full medication list
• •Anyone in that position should still ask why an approved single agent at a known dose would not do the same job for a third of the price

Limitations

• •The ondansetron interaction is the reason this review exists and the reason for the rating. Apomorphine's approved US labelling contraindicates concomitant use with 5HT3 antagonists including ondansetron, citing reports of profound hypotension and loss of consciousness. Ondansetron is not an obscure drug — it is the standard anti-nausea medication, and several GLP-1 telehealth providers we have reviewed this month offer it as a routine add-on for treatment nausea. A man on a weight-loss programme with Zofran in the cupboard is a completely ordinary scenario, and nothing in this product's marketing tells him not to combine the two.
• •Stacking two PDE5 inhibitors is the second problem and would be enough on its own. Sildenafil and tadalafil do the same thing by the same mechanism; taking both adds cardiovascular risk without an established benefit over an adequate dose of either, and every warning that applies to one applies more strongly to both — most critically the absolute contraindication with nitrates.
• •Put all three together and you have three agents that lower blood pressure in a single dissolving tablet, in a combination that has never been studied, at strengths that do not exist in any approved product. Nobody knows what this does to blood pressure in a man with borderline cardiac risk, because nobody has looked.
• •To be fair on the apomorphine dose: 3mg is modest against Parkinson's dosing and sublingual exposure differs from injection, so the nausea burden is likely far below what the Parkinson's labelling describes. That is a genuine mitigation and we do not want to overstate the case. It does not change the contraindication, which the label does not frame as dose-dependent, and it does not change the additive hypotension.
• •Skipping lab work matters more here than in most conditions. New erectile dysfunction is frequently the earliest sign of cardiovascular disease, diabetes or hypogonadism — and cardiovascular disease is precisely the condition in which a three-drug hypotensive stack is most dangerous. Treating the symptom online without assessing the cause gets that exactly backwards.
• •On value, the comparison is unflattering. $13.25 a dose for an unstudied compounded combination against $4 to $10 for FDA-approved generic sildenafil at a stated strength is a premium paid for additional uncertainty.

Alternatives to Consider

Frequently Asked Questions

Our Verdict

The one thing BraveRX does better than its closest competitor is tell you what is in the tablet. Sildenafil 40mg, tadalafil 15mg, apomorphine 3mg — disclosed clearly, where a rival selling a similar four-active sublingual publishes no strengths at all. The oral dissolving format genuinely does act faster than a swallowed pill, and bundling the consultation, support and shipping into one price is clean.

But knowing what is in it is what makes the problem visible. Two of the three actives are PDE5 inhibitors doing the same job by the same mechanism, at strengths that exist in no approved product, in a combination that adds cardiovascular risk without an established benefit over an adequate dose of either. The third, apomorphine, is a dopamine agonist that is not approved for erectile dysfunction anywhere in the United States. All three lower blood pressure. Nobody has studied what that does together, because compounded combinations are not studied.

The specific danger is one we have not seen flagged anywhere else. Apomorphine's approved labelling contraindicates concomitant use with ondansetron and other 5HT3 antagonists, on the basis of reported profound hypotension and loss of consciousness. Ondansetron is the standard anti-nausea drug — and several GLP-1 telehealth providers we have reviewed this month ship it as a routine add-on for treatment nausea. A man taking a compounded GLP-1 with Zofran in the cupboard, who then buys a compounded ED tablet containing apomorphine, has assembled a contraindicated combination out of two products neither of which warned him.

We rate BraveRX 1.5 out of 5 — the lowest rating we have given, and it is about the formulation rather than the company. If you want ED treatment online, Ro publishes FDA-approved generic sildenafil from $4 a dose and tadalafil from $8, at strengths you can name, for a fraction of $13.25. If you have any cardiac history, take nitrates or alpha-blockers, or have ondansetron in the house, do not take this without speaking to a clinician who can see your whole medication list.

This review is informational only and is not medical advice. Compounded medications are not FDA-approved and have not been evaluated for safety, efficacy or quality. PDE5 inhibitors interact dangerously with nitrates, and apomorphine is contraindicated with ondansetron. Speak to a licensed clinician before starting, changing or stopping any treatment.